Poor sleep and hepatic steatosis contribute to poorer quality of life in people with human immunodeficiency virus

Table 3 Factors associated with sleep quality in people with human immunodeficiency virus based on multivariate analysis

Variable	β estimate	95%CI	P value
Age	0.02	-0.001 to 0.04	0.07
Gender, ref: Male
Female	0.68	0.12-1.24	0.02
Transgender/gender diverse	0.58	-0.53 to 1071	0.3
Race/ethnicity, ref: Non-Hispanic White
Black	0.09	-0.39 to 0.59	0.7
Hispanic	0.18	-0.76 to 1.21	0.7
No long-term partner	0.61	0.03-1.18	0.04
Education: High school or above	1.00	0.34-1.67	0.002
Waist circumference, by 5 cm	-0.06	-0.14 to 0.03	0.2
Obstructive sleep apnea, ref: No sleep apnea
Not treated	1.27	0.40-2.13	0.004
Treated	1.33	0.61-2.04	< 0.001
Current smoker	0.31	-0.27 to 0.90	0.3
Food insecurity	0.97	0.44-1.49	< 0.001
Area deprivation index	-0.002	-0.01 to 0.005	0.5
MASLD, ref: Non-SLD
MASLD and LSM ≥ 8 kPa	0.26	-0.68 to 1.21	0.6
MASLD and LSM < 8 kPa	-0.30	-0.83 to 0.22	0.3
Health related quality of life
PCS	-0.13	-0.16 to -0.11	< 0.01
MCS	-0.15	-0.17 to -0.12	< 0.01

CI: Confidence interval; MASLD: Metabolic dysfunction-associated steatotic liver disease; Non-SLD: Non-steatotic liver disease; LSM: Liver stiffness measurement; PCS: Physical component summary score; MCS: Mental component summary score.